These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 8803917)

  • 21. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
    Marmor MF
    Retina; 2016 Oct; 36(10):1803-5. PubMed ID: 27388736
    [No Abstract]   [Full Text] [Related]  

  • 22. [Ophthalmologic prevention of chloroquine and hydroxychloroquine induced retinopathy].
    Bui Quoc E; Ingster-Moati I; Rigolet MH; Chosidow O; Bodaghi B
    Ann Dermatol Venereol; 2005 Apr; 132(4):329-37. PubMed ID: 15886559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Routine monitoring of patients treated with synthetic antimalarials].
    Douche C; Bechetoille A; Ebran JM
    J Fr Ophtalmol; 1983; 6(8-9):689-95. PubMed ID: 6677659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
    Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
    Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Severe chloroquine- and hydroxychloroquine-induced retinopathy].
    Ingster-Moati I; Bui Quoc E; Crochet M; Orssaud C; Dufier JL; Roche O
    J Fr Ophtalmol; 2006 Jun; 29(6):642-50. PubMed ID: 16885894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Supervision of the eyes during prolonged treatment with synthetic antimalarial drugs. Results in 237 patients followed up for 4 years on the average].
    Bertrand JJ; Debeyre N; Kahn MF; Ryckewaert A
    Presse Med (1893); 1968 Nov; 76(45):2139-42. PubMed ID: 5720115
    [No Abstract]   [Full Text] [Related]  

  • 27. The multifocal pattern electroretinogram in chloroquine retinopathy.
    Neubauer AS; Stiefelmeyer S; Berninger T; Arden GB; Rudolph G
    Ophthalmic Res; 2004; 36(2):106-13. PubMed ID: 15017107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. More thoughts about antimalarials: should one prescribe chloroquine?
    Esdaile JM
    J Rheumatol; 1999 Sep; 26(9):1868. PubMed ID: 10493663
    [No Abstract]   [Full Text] [Related]  

  • 29. Accuracy of Amsler grid in screening for chloroquine retinopathy.
    Suansilpong A; Uaratanawong S
    J Med Assoc Thai; 2010 Apr; 93(4):462-6. PubMed ID: 20462090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy.
    Bernstein HN
    Am J Med; 1983 Jul; 75(1A):25-34. PubMed ID: 6869408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chloroquine-induced ocular toxicity.
    Petrohelos MA
    Ann Ophthalmol; 1974 Jun; 6(6):615-8. PubMed ID: 4836611
    [No Abstract]   [Full Text] [Related]  

  • 32. RE: Microperimetry and the diagnosis of antimalarial maculopathy.
    Easterbrook M
    Can J Ophthalmol; 2014 Jun; 49(3):307-8. PubMed ID: 24862782
    [No Abstract]   [Full Text] [Related]  

  • 33. Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment.
    Rynes RI
    Am J Med; 1983 Jul; 75(1A):35-9. PubMed ID: 6869409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.
    Jiménez-Alonso J; Tercedor J; Jáimez L; García-Lora E
    Arthritis Rheum; 1998 Apr; 41(4):744-5. PubMed ID: 9550488
    [No Abstract]   [Full Text] [Related]  

  • 35. [Macular complications of synthetic antimalarials. Apropos of a case].
    Ducousso F; Ballion JC; Kovalski JL; Labrouze JM; Bazin S; Bourguignon G; Saliou G
    J Fr Ophtalmol; 1995; 18(8-9):553-8. PubMed ID: 7560802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 37. Long-term use of antimalarial drugs in rheumatic diseases.
    Jover JA; Leon L; Pato E; Loza E; Rosales Z; Matias MA; Mendez-Fernandez R; Díaz-Valle D; Benitez-Del-Castillo JM; Abasolo L
    Clin Exp Rheumatol; 2012; 30(3):380-7. PubMed ID: 22339928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of Antimalarial Therapy in Patients Who Are Hypersensitive to Hydroxychloroquine.
    Riley K; Schwager Z; Stern M; Vleugels RA; Femia A
    JAMA Dermatol; 2019 Apr; 155(4):491-493. PubMed ID: 30758479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular toxicity of antimalarial drugs. Long-term follow-up.
    Carr RE; Henkind P; Rothfield N; Siegel IM
    Am J Ophthalmol; 1968 Oct; 66(4):738-44. PubMed ID: 5729592
    [No Abstract]   [Full Text] [Related]  

  • 40. Chloroquine-induced retinal toxicity.
    Whitelaw D; Jessop S
    S Afr Med J; 2005 Feb; 95(2):72. PubMed ID: 15751191
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.